Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-04-5/5 · Tested by Janoshik Analytical · 26/05/2026
View COA
Tissue Repair Research

BPC-157 + TB-500 10mg

Be the first to review SKU: APC-BPC-157-PLUS-TB-500-10MG5MG5MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$99.99 AUD
In Stock
Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day
Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

BPC-157 + TB-500 is a pre-blended research formulation combining two peptides studied in experimental models involving cellular responses, vascular signalling and tissue-associated pathways. BPC-157 is a synthetic 15-amino-acid peptide, while TB-500 is associated with research into mechanisms related to thymosin β4 biology. This blend is supplied in Australia strictly as a laboratory research material. Exact strength, composition, purity and batch-testing information should be confirmed against the current product documentation.

What Is BPC-157 + TB-500?

BPC-157 is a synthetic pentadecapeptide primarily investigated in preclinical research. Experimental studies have examined its relationship with vascular signalling, endothelial responses and nitric-oxide-associated mechanisms. Evidence remains largely preclinical and does not establish therapeutic benefits in humans.

TB-500 is commonly associated with research into thymosin β4-related mechanisms. Thymosin β4 is an actin-binding peptide studied for its role in cytoskeletal organisation, cellular migration and angiogenic processes.

Studying BPC-157 and TB-500 together enables researchers to examine distinct but potentially overlapping biological pathways within a single experimental model. Evidence demonstrating that the combination itself produces synergistic effects remains limited.

ManufacturerZynova Labs
Strength10mg (5mg + 5mg)
Purity≥99.0% (HPLC, batch ZL-04-5/5)
AppearanceWhite lyophilised powder
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryTissue Repair Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

BPC-157 + TB-500 research has focused on several experimental areas, including:

BPC-157 has been investigated in relation to VEGFR2-Akt-eNOS signalling and vascular mechanisms. Thymosin β4 research has separately examined actin binding, cell migration and angiogenesis.

These findings originate primarily from laboratory, animal or other preclinical models and should not be interpreted as evidence of established human effects.

Why Researchers Study BPC-157 + TB-500

The scientific interest in this blend comes from the different experimental mechanisms associated with each component.

BPC-157 research has examined vascular and endothelial signalling pathways. Thymosin β4-related research has focused on actin binding, cytoskeletal regulation, cellular migration and extracellular matrix processes.

These different mechanisms provide a rationale for investigating both compounds within the same experimental system. However, it should not be assumed that combining BPC-157 and TB-500 makes either compound more effective. The complementary activity represents an area for experimental investigation rather than a demonstrated clinical advantage.

Key Research Areas at a Glance

Cellular migration and signalling
Angiogenesis and endothelial responses
Cytoskeletal and actin-associated mechanisms
Extracellular matrix processes
Inflammatory signalling pathways
Vascular responses
Experimental tissue models

BPC-157 + TB-500 in Australia

Researchers searching for BPC-157 + TB-500 Australia should consider analytical documentation, verified composition and batch testing when comparing research materials.

Before purchasing BPC-157 + TB-500 online, researchers should check the current vial strength, blend ratio, BPC-157 + TB-500 price, stock status and Australian shipping information.

Where available, a batch-specific CoA provides additional information about the analytical characteristics of the supplied material.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameBPC-157 + TB-500 10mg
ManufacturerZynova Labs
Strength10mg (5mg + 5mg)
Purity≥99.0% (HPLC, batch ZL-04-5/5)
AppearanceWhite lyophilised powder
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryTissue Repair Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

Researchers should assess BPC-157 + TB-500 using product-specific analytical documentation. The product listing should clearly identify the nominal quantity per vial and the amount of each component in the blend.

Where verified, information should include stated purity, analytical methods such as HPLC or mass spectrometry, and batch-specific Certificate of Analysis documentation.

A CoA can provide useful information regarding identity, composition and analytical purity. However, analytical purity does not demonstrate clinical safety, therapeutic effectiveness or suitability for human use.

CERTIFICATE OF ANALYSIS
BPC-157 + TB-500 10mg (5mg + 5mg)
Batch: ZL-04-5/5 · 26/05/2026
Janoshik Analytical Certificate of Analysis for BPC-157 + TB-500 10mg

Storage & Handling

Storage and Laboratory Handling

  • Lyophilised Storage: Follow the verified conditions stated on the product label, Certificate of Analysis or accompanying batch documentation.
  • After Reconstitution: Researchers should follow validated laboratory procedures and available batch documentation. Post-reconstitution storage temperatures, solvents, concentrations and stability periods should not be assumed where product-specific validation is unavailable.

Appropriate laboratory handling helps maintain sample integrity during controlled experimental work.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: BPC-157 + TB-500 10mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

BPC-157 + TB-500 10mg: Frequently Asked Questions

It is a pre-blended research formulation combining BPC-157 with TB-500 for controlled laboratory investigation.

The components are investigated through different pathways involving vascular signalling, cellular migration, cytoskeletal regulation and related experimental mechanisms.

Researchers study them together because their distinct mechanisms allow multiple biological pathways to be examined within one experimental model.

Research areas include cellular signalling, angiogenesis, endothelial responses, cytoskeletal processes, cellular migration and experimental tissue models.

Purity and testing information should be confirmed from the current product specification and batch-specific analytical documentation.

Where supplied, a batch-specific CoA may document identity, composition, purity and relevant analytical results.

Researchers should follow the verified storage conditions provided with the product and relevant batch documentation.

Researchers can order from Australian research-peptide suppliers where legally available. Check current stock, price, testing documentation and domestic shipping information before ordering.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “BPC-157 + TB-500 10mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products